Dr. Miguel Loya, D.O

NPI: 1619281532
Total Payments
$2,323
2022 Payments
$19.87
Companies
28
Transactions
158
Medicare Patients
4,695
Medicare Billing
$499,153

Payment Breakdown by Category

Food & Beverage$2,280 (98.1%)
Education$43.00 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,280 156 98.1%
Education $43.00 2 1.9%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $396.84 26 $0 (2020)
PFIZER INC. $391.38 32 $0 (2020)
AstraZeneca Pharmaceuticals LP $295.40 15 $0 (2019)
Supernus Pharmaceuticals, Inc. $226.06 12 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $148.18 9 $0 (2020)
Janssen Pharmaceuticals, Inc $116.54 6 $0 (2020)
Takeda Pharmaceuticals America, Inc. $96.38 15 $0 (2017)
Amgen Inc. $87.81 5 $0 (2018)
ABBVIE INC. $55.10 3 $0 (2022)
SANOFI-AVENTIS U.S. LLC $53.30 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $19.87 1 ABBVIE INC. ($19.87)
2021 $59.05 4 AbbVie Inc. ($35.23)
2020 $193.13 13 PFIZER INC. ($53.64)
2019 $506.66 39 PFIZER INC. ($109.53)
2018 $650.78 36 AstraZeneca Pharmaceuticals LP ($129.62)
2017 $893.21 65 Allergan Inc. ($183.73)

All Payment Transactions

158 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
06/29/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $19.87 General
Category: NEUROSCIENCE
11/17/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.05 General
Category: Gastroenterology
06/29/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.77 General
Category: Gastroenterology
06/21/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $21.82 General
Category: NEUROSCIENCE
04/14/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $13.41 General
Category: NEUROSCIENCE
10/28/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.82 General
Category: GASTROENTEROLOGY
09/29/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $15.89 General
Category: Central Nervous System
09/24/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $14.33 General
Category: Diabetes
09/22/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $16.35 General
Category: NEUROSCIENCE
08/24/2020 Boehringer Ingelheim Pharmaceuticals, Inc. PRADAXA (Drug), JARDIANCE Food and Beverage In-kind items and services $14.64 General
Category: CARDIOVASCULAR
08/11/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $17.81 General
Category: NEUROSCIENCE
07/30/2020 PFIZER INC. CHANTIX (Drug), COLOGUARD Food and Beverage In-kind items and services $14.26 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
07/28/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.41 General
Category: Cardiovascular & Metabolism
07/21/2020 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $21.50 General
Category: AED
03/10/2020 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.54 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/26/2020 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $13.73 General
Category: VACCINES
01/23/2020 SANOFI PASTEUR INC. FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, PENTACEL Food and Beverage In-kind items and services $11.74 General
Category: Vaccines
01/07/2020 PFIZER INC. CHANTIX (Drug), COLOGUARD Food and Beverage In-kind items and services $11.11 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
12/19/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.46 General
Category: Cardiovascular and Metabolism
12/04/2019 PFIZER INC. CHANTIX (Drug), EUCRISA, COLOGUARD Food and Beverage In-kind items and services $6.11 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
12/03/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.50 General
Category: NEUROSCIENCE
11/25/2019 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $11.03 General
Category: AED
11/19/2019 PFIZER INC. CHANTIX (Drug), EUCRISA, COLOGUARD Food and Beverage In-kind items and services $5.42 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
11/06/2019 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $18.61 General
Category: AED
11/04/2019 SANOFI-AVENTIS U.S. LLC TOUJEO (Drug) Food and Beverage In-kind items and services $17.94 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 1,470 1,916 $471,993 $154,345
2022 20 1,197 1,513 $391,550 $133,156
2021 18 1,122 1,381 $370,130 $126,124
2020 16 906 1,234 $252,181 $85,529
Total Patients
4,695
Total Services
6,044
Medicare Billing
$499,153
Procedure Codes
76

All Medicare Procedures & Services

76 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 341 341 $107,756 $47,157 43.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 245 406 $143,318 $37,350 26.1%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 54 54 $35,748 $15,155 42.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 144 201 $50,049 $12,378 24.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 172 172 $26,660 $6,752 25.3%
90662 Influenza vaccine split virus, preservative free Office 2023 76 76 $12,464 $5,436 43.6%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 22 27 $13,662 $4,568 33.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 25 25 $10,869 $4,400 40.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 28 29 $10,353 $2,782 26.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 27 43 $8,127 $2,733 33.6%
G0008 Administration of influenza virus vaccine Office 2023 83 83 $5,727 $2,731 47.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 24 25 $7,433 $2,372 31.9%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 21 23 $7,688 $2,108 27.4%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 11 11 $4,946 $1,932 39.1%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 25 29 $6,826 $1,606 23.5%
G0009 Administration of pneumococcal vaccine Office 2023 46 46 $3,174 $1,513 47.7%
96372 Injection of drug or substance under skin or into muscle Office 2023 13 110 $7,590 $1,267 16.7%
20610 Aspiration and/or injection of fluid from large joint Office 2023 18 22 $4,730 $1,107 23.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 50 51 $3,407 $598.08 17.6%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 15 21 $546.00 $167.81 30.7%
69209 Removal of impacted ear wax by washing Office 2023 12 13 $607.00 $156.22 25.7%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 18 108 $313.20 $78.13 24.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 294 294 $92,904 $41,941 45.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 219 359 $126,727 $35,290 27.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 156 189 $47,061 $12,176 25.9%

About Dr. Miguel Loya, D.O

Dr. Miguel Loya, D.O is a Internal Medicine healthcare provider based in Solvang, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619281532.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miguel Loya, D.O has received a total of $2,323 in payments from pharmaceutical and medical device companies, with $19.87 received in 2022. These payments were reported across 158 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,280).

As a Medicare-enrolled provider, Loya has provided services to 4,695 Medicare beneficiaries, totaling 6,044 services with total Medicare billing of $499,153. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Solvang, CA
  • Active Since 08/03/2010
  • Last Updated 03/28/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1619281532

Products in Payments

  • TROKENDI XR (Drug) $210.65
  • ELIQUIS (Drug) $188.17
  • BEVESPI AEROSPHERE (Drug) $177.31
  • VRAYLAR (Drug) $144.28
  • FARXIGA (Drug) $107.36
  • BYSTOLIC (Drug) $75.72
  • Trintellix (Drug) $72.28
  • JARDIANCE (Drug) $70.84
  • Prolia (Biological) $70.18
  • XARELTO (Drug) $70.02
  • UBRELVY (Drug) $69.39
  • LYRICA (Drug) $62.01
  • LINZESS (Drug) $57.82
  • CHANTIX (Drug) $52.21
  • PRADAXA (Drug) $51.44
  • VIAGRA (Drug) $51.35
  • XIFAXAN (Drug) $47.26
  • INVOKANA (Drug) $46.52
  • LONHALA MAGNAIR (Drug) $45.06
  • BYVALSON (Drug) $37.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Solvang